1 results match your criteria: "Florence bItalian Institute of Telemedicine[Affiliation]"
Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study.
J Hypertens
March 2016
aDepartment of Clinical and Experimental Medicine, Careggi Hospital, University of Florence, Florence bItalian Institute of Telemedicine, Varese cThe ZEUS Study Group, Italy dThe ZEUS Study Group, Romania.
Objective: To compare zofenopril + hydrochlorothiazide (Z + H) vs. irbesartan + hydrochlorothiazide (I + H) efficacy on daytime SBP in elderly (>65 years) patients with isolated systolic hypertension (ISH), untreated or uncontrolled by a previous monotherapy.
Methods: After a 1-week run-in, 230 ISH patients (office SBP ≥ 140 mmHg and DBP < 90 mmHg + daytime SBP ≥ 135 mmHg and daytime DBP < 85 mmHg) were randomized double-blind to 18-week treatment with Z + H (30 + 12.